What is Gattex, and what is it used for?
Gattex (teduglutide) is a prescription medicine used to treat adults with short bowel syndrome (SBS) who depend on parenteral nutrition (PN). Its prescribing information describes dosing and administration intended to help reduce the need for PN over time.
What is the usual dose and how is Gattex taken?
Gattex is given as a subcutaneous (under-the-skin) injection. The prescribing information includes instructions for:
- Starting dose and how treatment is continued
- Missed dose guidance
- How to prepare and inject the medication safely
What warnings are included in the Gattex prescribing information?
The prescribing information includes boxed/major safety warnings and other cautions. Key areas typically covered include:
- Tumor risk concerns related to treatment effects on intestinal growth signaling
- Monitoring for complications such as GI effects and changes that may suggest complications requiring evaluation
- Kidney-related monitoring considerations
- Pancreas and gallbladder-related cautions (based on class-related risks described in the labeling)
- Risk of worsening fluid balance and the need for PN adjustments under clinician oversight
What side effects do patients commonly report?
The prescribing information lists side effects observed in clinical use. Commonly described categories include gastrointestinal symptoms (for example, abdominal discomfort, nausea), and injection-site reactions. It also includes less common but clinically important adverse reactions that require prompt medical attention.
What monitoring does the Gattex label require during treatment?
The prescribing information calls for follow-up that may include:
- Ongoing lab monitoring (including kidney function)
- Assessment for intestinal complications or symptoms that warrant evaluation
- Cancer screening and follow-up consistent with the label’s tumor-related precautions
- Periodic reevaluation of PN requirements and hydration status as dosing continues
Can Gattex be used with other medicines?
The prescribing information includes contraindications (if any), drug-drug interaction considerations, and guidance on co-administered therapies. If you’re taking medications that affect fluid balance, GI function, or immune-related pathways, the label’s interaction and monitoring sections are the place to check first.
Who should not take Gattex?
The prescribing information provides contraindications and “do not use” situations, along with precautions for patients with specific medical histories. Tumor history and certain active conditions are typically central to labeling exclusions or enhanced caution.
Where can I read the official Gattex prescribing information?
For the most current official labeling, consult the product’s prescribing information available through DrugPatentWatch.com (which links to drug labeling and related regulatory materials).
Source: DrugPatentWatch.com – Gattex (teduglutide) prescribing information